Hôpitaux Universitaires de Genève

Geneva, Switzerland

11 recruiting

Showing 120 of 26 trials

Recruiting
Phase 1

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Diffuse Large B-Cell Lymphoma (DLBCL)Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)+6 more
Nurix Therapeutics, Inc.572 enrolled62 locationsNCT05131022
Recruiting
Not Applicable

The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema

Lymphedema, Breast Cancer
University Hospital, Basel, Switzerland280 enrolled36 locationsNCT05890677
Recruiting

Neurovascular Product Surveillance Registry

Stroke, IschemicIntracranial Aneurysm
Medtronic Neurovascular Clinical Affairs4,000 enrolled99 locationsNCT02988128
Recruiting
Not Applicable

ELEVATE-HFpEF Clinical Study

Heart Failure With Preserved Ejection Fraction (HFpEF)
Medtronic Cardiac Rhythm and Heart Failure700 enrolled44 locationsNCT06678841
Recruiting
Not Applicable

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

HypertensionHypertension, SystolicHypertension,Essential
Orchestra BioMed, Inc500 enrolled129 locationsNCT06059638
Recruiting
Phase 4

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

Atrial Fibrillation (AF)Percutaneous Coronary Intervention (PCI)Oral Anticoagulation+1 more
Insel Gruppe AG, University Hospital Bern3,010 enrolled15 locationsNCT05955365
Recruiting
Not Applicable

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery

Breast Cancer
University Hospital, Basel, Switzerland1,060 enrolled54 locationsNCT07140172
Recruiting
Not Applicable

Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation

COVID19Olfactory Dysfunction
Universitaire Ziekenhuizen KU Leuven240 enrolled7 locationsNCT06482138
Recruiting
Not Applicable

Hybrid Micro-macro Electrodes in Patients With Epilepsy

Epilepsy
Pierre Mégevand30 enrolled2 locationsNCT05335187
Recruiting
Not Applicable

The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters

Uterine Fibroid
University Hospital, Geneva30 enrolled1 locationNCT07173127
Recruiting
Not Applicable

Moderate Alcohol Consumption and Heart Function in Patients With a Recent Myocardial Infarction

Myocardial Infarction
Baris Gencer220 enrolled4 locationsNCT05920629
Recruiting
Phase 2

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

Metastatic NSCLC - Non-Small Cell Lung Cancer
Swiss Cancer Institute156 enrolled17 locationsNCT07020065
Recruiting

Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors

Diabete Type 2RegurgitationPulmonary Aspiration During Anaesthetic Induction
University Hospital, Geneva38 enrolled1 locationNCT07506356
Recruiting
Not Applicable

Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in NICU.

Infection, BacterialInfection Prevention
PENTA Foundation3,080 enrolled24 locationsNCT05993442
Recruiting
Phase 3

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

Peripheral Arterial DiseaseInflammationAtherosclerosis of Extremities
Population Health Research Institute6,150 enrolled70 locationsNCT04774159
Recruiting
Phase 2Phase 3

Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma

Hepato Cellular Carcinoma (HCC)
University Hospital, Basel, Switzerland152 enrolled3 locationsNCT07302919
Recruiting
Phase 2

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients

COVID-19Immunodeficiency
Calmy Alexandra256 enrolled4 locationsNCT07406217
Recruiting
Phase 3

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

Melanoma Stage IIIBMelanoma Stage IIICMelanoma Stage IIID
Philogen S.p.A.186 enrolled37 locationsNCT03567889
Recruiting
Phase 3

A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections

Gram-negative InfectionsSepsis and septic shock
Angela HUTTNER100 enrolled1 locationNCT07063095
Recruiting
Phase 3

MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

High-grade Serous Ovarian Carcinoma (HGSOC)Fallopian Tube NeoplasmsOvarian Neoplasm Epithelial+3 more
Swiss GO Trial Group540 enrolled53 locationsNCT04111978